You are here
Roundtable Webcast: Emerging Anti-Angiogenesis Therapies in Pleural Mesothelioma
In this roundtable discussion, three key opinion leaders exchange their views on the promise of emerging anti-angiogenics in malignant pleural mesothelioma (MPM). They will examine the latest clinical trial data and future directions in MPM treatment.
Interactive Patient Case: Multidisciplinary Management of Malignant Pleural Mesothelioma
How can the management of malignant pleural mesothelioma (MPM) be optimized? This interactive patient case will guide you through best practices in diagnosis and treatment, including options for resectable and unresectable disease.
David J. Sugarbaker, MD
Baylor College of Medicine, Lung Institute, and Division of Thoracic Surgery
Baylor St. Luke's Medical Center
Houston, TX, USA
Jointly provided by the Elsevier Office of Continuing Medical Education and Excerpta Medica.